Literature DB >> 19352594

Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour.

Julien Domont1, Christophe Massard, Nathalie Lassau, Jean-Pierre Armand, Axel Le Cesne, Jean-Charles Soria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19352594     DOI： 10.1007/s10637-009-9249-1

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  4 in total

Review 1.  Targeting angiogenesis for the treatment of sarcoma.

Authors:  Lakshmi Balasubramanian; Andrew M Evens
Journal:  Curr Opin Oncol       Date:  2006-07       Impact factor: 3.645

Review 2.  Solitary fibrous tumour and haemangiopericytoma: evolution of a concept.

Authors:  C Gengler; L Guillou
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

Review 3.  Markers of angiogenesis and clinical features in patients with sarcoma.

Authors:  Steven DuBois; George Demetri
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

4.  Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Authors:  Sandrine Faivre; Catherine Delbaldo; Karina Vera; Caroline Robert; Stéphanie Lozahic; Nathalie Lassau; Carlo Bello; Samuel Deprimo; Nicoletta Brega; Giorgio Massimini; Jean-Pierre Armand; Paul Scigalla; Eric Raymond
Journal:  J Clin Oncol       Date:  2005-11-28       Impact factor: 44.544
  4 in total
  19 in total

1.  Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas.

Authors:  Margaret von Mehren; Cathryn Rankin; John R Goldblum; George D Demetri; Vivien Bramwell; Christopher W Ryan; Ernest Borden
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

2.  Intracranial meningeal hemangiopericytoma: Recurrences at the initial and distant intracranial sites and extraneural metastases to multiple organs.

Authors:  Guangquan Wei; Xiaowei Kang; Xianping Liu; Xing Tang; Qinlong Li; Juntao Han; Hong Yin
Journal:  Mol Clin Oncol       Date:  2015-04-02

Review 3.  Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.

Authors:  Vittoria Colia; Salvatore Provenzano; Nadia Hindi; Paolo G Casali; Silvia Stacchiotti
Journal:  Rep Pract Oncol Radiother       Date:  2016-01-13

4.  Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib.

Authors:  Silvia Stacchiotti; Gian Paolo Dagrada; Carlo Morosi; Tiziana Negri; Antonella Romanini; Silvana Pilotti; Alessandro Gronchi; Paolo G Casali
Journal:  Clin Sarcoma Res       Date:  2012-10-11

5.  Anti-angiogenic treatment (sunitinib) for disseminated malignant haemangiopericytoma: a case study and review of the literature.

Authors:  M Delgado; E Pérez-Ruiz; J Alcalde; D Pérez; R Villatoro; A Rueda
Journal:  Case Rep Oncol       Date:  2011-02-05

6.  The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis.

Authors:  Min S Park; Vinod Ravi; Anthony Conley; Shreyaskumar R Patel; Jonathan C Trent; Dina C Lev; Alexander J Lazar; Wei-Lien Wang; Robert S Benjamin; Dejka M Araujo
Journal:  Clin Sarcoma Res       Date:  2013-05-11

7.  Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Authors:  Alice Levard; Olfa Derbel; Pierre Méeus; Dominique Ranchère; Isabelle Ray-Coquard; Jean-Yves Blay; Philippe A Cassier
Journal:  BMC Cancer       Date:  2013-03-11       Impact factor: 4.430

8.  Solitary fibrous tumors and so-called hemangiopericytoma.

Authors:  Nicolas Penel; Eric Yaovi Amela; Gauthier Decanter; Yves-Marie Robin; Perrine Marec-Berard
Journal:  Sarcoma       Date:  2012-04-08

9.  Synchronous papillary carcinoma and hemangiopericytoma with lung metastases.

Authors:  Nicola Malagutti; Valeria Iannini; Andrea Rocchi; Francesco Stomeo; Antonio Frassoldati; Michela Borin; Stefano Pelucchi
Journal:  Case Rep Otolaryngol       Date:  2013-12-04

10.  Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy.

Authors:  M Tazzari; T Negri; F Rini; B Vergani; V Huber; A Villa; P Dagrada; C Colombo; M Fiore; A Gronchi; S Stacchiotti; P G Casali; S Pilotti; L Rivoltini; C Castelli
Journal:  Br J Cancer       Date:  2014-08-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.